Intranasal oxytocin administration dampens amygdala reactivity towards emotional faces in male and female PTSD patients
Open accessAbstract
Post-traumatic stress disorder (PTSD) is a disabling psychiatric disorder. As a substantial part of PTSD patients responds poorly to currently available psychotherapies, pharmacological interventions boosting treatment response are needed. Because of its anxiolytic and pro-social properties, the neuropeptide oxytocin (OT) has been proposed as promising strategy for treatment augmentation in PTSD. As a first step to investigate the therapeutic potential of OT in PTSD, we conducted a double-blind, placebo-controlled, cross-over functional MRI study examining OT administration effects (40 IU) on amygdala reactivity toward emotional faces in unmedicated male and female police officers with (n=37, 21 males) and without (n=40, 20 males) PTSD. Trauma-exposed controls were matched to PTSD patients based on age, sex, years of service and educational level. Under placebo, the expected valence-dependent amygdala reactivity (ie, greater activity toward fearful-angry faces compared with happy-neutral faces) was absent in PTSD patients. OT administration dampened amygdala reactivity toward all emotional faces in male and female PTSD patients, but enhanced amygdala reactivity in healthy male and female trauma-exposed controls, independent of sex and stimulus valence. In PTSD patients, greater anxiety prior to scanning and amygdala reactivity during the placebo session were associated with greater reduction of amygdala reactivity after OT administration. Taken together, our results indicate presumably beneficial neurobiological effects of OT administration in male and female PTSD patients. Future studies should investigate OT administration in clinical settings to fully appreciate its therapeutic potential.
AI snapshot
Written from the paper’s full text.
TL;DR
In a double-blind, placebo-controlled crossover fMRI study, intranasal oxytocin (40 IU) dampened left amygdala reactivity toward emotional faces in male and female PTSD patients but enhanced it in trauma-exposed controls. The dampening effect was strongest in PTSD patients with higher pre-scan anxiety and higher placebo-session amygdala reactivity.
Key findings
- Under placebo, trauma-exposed controls showed greater left amygdala reactivity to fearful-angry versus happy-neutral faces (P_FWE < 0.001), whereas this valence-dependent pattern was absent in PTSD patients (P_FWE = 0.359).
- Oxytocin administration produced a significant group-by-medication interaction in the left amygdala (P_FWE = 0.047): it dampened left amygdala reactivity in PTSD patients (P_FWE = 0.034) and enhanced it in trauma-exposed controls (P_FWE = 0.016), independent of sex and stimulus valence.
- In PTSD patients, higher state anxiety before placebo was positively related to left amygdala reactivity under placebo (r = 0.393, p = 0.021), and greater placebo-session amygdala reactivity mediated greater oxytocin-related dampening (indirect effect 95% CI = 0.0018–0.0248).
- No significant associations were found between left amygdala reactivity and CAPS total score or subscales (all p > 0.05).
Methods
- Randomized, double-blind, placebo-controlled, crossover fMRI study of intranasal oxytocin (40 IU Syntocinon) versus saline in unmedicated male and female police officers with PTSD and trauma-exposed controls matched on age, sex, years of service, and education.
- The abstract reports n = 37 PTSD patients (21 males) and n = 40 trauma-exposed controls (20 males); after exclusions for scanner artifacts and signal dropout, 36 PTSD patients (21 males) and 37 controls (18 males) were analyzed, and correlation analyses used 35 PTSD patients after excluding one female outlier.
- Participants completed an emotional face-matching task with fearful-angry and happy-neutral faces versus a visuomotor control condition, scanned on average 44.68 ± 3.74 minutes after spray; fMRI analysis used SPM8 with bilateral amygdala ROIs, FWE small-volume correction, and second-level ANOVA with task condition and medication as within-subject factors and group and sex as between-subject factors.
Limitations
- The paper states that females using oral contraceptives were included, menstrual cycle phase was not standardized, and the trauma-exposed police control sample limits generalizability.
- The paper notes that oxytocin effects were lateralized to the left amygdala, with the same directionality but non-significant effects in the right amygdala.
- Evident from the text: the study examined acute neurobiological effects only, not clinical treatment outcomes, and the authors suggest future clinical studies are needed before routine application.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 46 cited sources checked · 0 supported · 0 flagged
- Findingown data
OT administration enhanced amygdala reactivity in healthy male and female trauma-exposed controls.
“OT administration dampened amygdala reactivity toward all emotional faces in male and female PTSD patients, but enhanced amygdala reactivity in healthy male and female traumaexposed controls, independent of sex and stimulus valence.”
Quote in the paperSubstantial claim - Findingown data
Under placebo, trauma-exposed controls showed greater left amygdala reactivity toward fearful-angry faces compared with happy-neutral faces.
“Post hoc t-tests showed that left amygdala was significantly more activated in traumaexposed controls in response to fearful-angry faces compared with happy-neutral faces (P FWE o0.001).”
Quote in the paperSubstantial claim - Findingown data
In PTSD patients, right amygdala activity was significantly higher during fearful-angry compared with happy-neutral faces under placebo.
“Right amygdala activity was significantly higher during fearful-angry compared with happy-neutral faces both in trauma-exposed controls (P FWE o0.001) and PTSD patients (P FWE = 0.005).”
Quote in the paperSubstantial claim - Findingown data
In PTSD patients, the difference in left amygdala contrast estimates between OT and placebo was trend-significantly positively related to state anxiety prior to placebo administration.
“In addition, the difference in contrast estimates between OT and placebo administration was trend significant positively related to state anxiety prior to placebo administration (r = 0.298, p = 0.089, Figure 3).”
Quote in the paperNot a substantial claim - Findingown data
No significant associations between left amygdala reactivity toward emotional faces and CAPS total score or subscales were found.
“No significant associations between left amygdala reactivity toward emotional faces and CAPS total score or subscales were found (all p40.05).”
Quote in the paperNot a substantial claim
- Findingown data
There was no significant main effect of OT administration on left and right amygdala reactivity toward emotional faces.
“No significant main effect of OT administration on left and right amygdala reactivity toward emotional faces was found (all P FWE 40.05).”
Quote in the paperSubstantial claim - Findingown data
Under placebo, the expected valence-dependent amygdala reactivity was absent in PTSD patients.
“Under placebo, the expected valence-dependent amygdala reactivity (ie, greater activity toward fearful-angry faces compared with happy-neutral faces) was absent in PTSD patients.”
Quote in the paperSubstantial claim - Findingown data
The emotional face-matching task reliably activated the bilateral amygdala.
“As expected, the emotional face-matching task reliably activated the bilateral amygdala (P FWE o0.05, main effect of condition, collapsed across all participants and all emotional faces).”
Quote in the paperSubstantial claim - Findingown data
There was a significant group by medication interaction effect for the left amygdala.
“A significant group by medication interaction effect was found for the left amygdala (P FWE = 0.047, see Figure 2; Table 2), but not for the right amygdala (P FWE = 0.188).”
Quote in the paperSubstantial claim - Findingown data
In PTSD patients, state anxiety prior to OT administration was not related to left amygdala reactivity toward emotional faces after OT administration.
“State anxiety prior to OT administration was not related to left amygdala reactivity toward emotional faces after OT administration (r = 0.064, p = 0.731)”
Quote in the paperNot a substantial claim - Findingown data
In PTSD patients, state anxiety prior to placebo administration was positively related to left amygdala reactivity toward emotional faces under placebo.
“Subjective anxiety of patients prior to intranasal placebo administration was positively related to left amygdala reactivity toward emotional faces under placebo (r = 0.393, p = 0.021, Figure 3).”
Quote in the paperNot a substantial claim - Findingown data
Direct comparison of amygdala reactivity toward fearful-angry faces and happy-neutral faces between PTSD patients and trauma-exposed controls revealed no significant differences.
“Direct post hoc comparison of amygdala reactivity toward fearful-angry faces and happy-neutral faces between PTSD patients and trauma-exposed controls revealed no significant differences (all P FWE 40.05).”
Quote in the paperNot a substantial claim - Findingown data
OT administration dampened amygdala reactivity toward all emotional faces in male and female PTSD patients.
“OT administration dampened amygdala reactivity toward all emotional faces in male and female PTSD patients, but enhanced amygdala reactivity in healthy male and female traumaexposed controls, independent of sex and stimulus valence.”
Quote in the paperSubstantial claim - Findingown data
In PTSD patients, left amygdala reactivity did not differ between fearful-angry and happy-neutral faces under placebo.
“In PTSD patients, however, this valence-dependent amygdala reactivity was absent for the left amygdala (P FWE = 0.359).”
Quote in the paperSubstantial claim - Findingown data
In PTSD patients, OT administration dampened left amygdala reactivity compared with placebo.
“Further testing using post hoc t-tests revealed enhanced left amygdala reactivity in traumaexposed controls (P FWE = 0.016) and dampened left amygdala reactivity (P FWE = 0.034) in PTSD patients after OT administration compared with placebo.”
Quote in the paperSubstantial claim - Findingown data
Across all participants, fearful-angry faces elicited more bilateral amygdala reactivity than happy-neutral faces.
“In addition, a main effect of task condition was found in which the fearful-angry faces elicited more bilateral amygdala reactivity than happy-neutral faces (P FWE o0.001).”
Quote in the paperNot a substantial claim - Findingown data
In PTSD patients, the effect of state anxiety on OT-related reduction in left amygdala reactivity was mediated by left amygdala reactivity after placebo administration.
“Notably, this effect was mediated by left amygdala reactivity after placebo administration (indirect effect: 95% confidence interval = 0.0018-0.0248,effect = 0.0114, Boot SE = 0.057)”
Quote in the paperNot a substantial claim - Findingown data
In trauma-exposed controls, OT administration enhanced left amygdala reactivity compared with placebo.
“Further testing using post hoc t-tests revealed enhanced left amygdala reactivity in traumaexposed controls (P FWE = 0.016) and dampened left amygdala reactivity (P FWE = 0.034) in PTSD patients after OT administration compared with placebo.”
Quote in the paperNot a substantial claim - Findingown data
OT administration dampened left amygdala reactivity in male and female PTSD patients.
“Taken together, we showed that OT administration dampened left amygdala reactivity in male and female PTSD patients, which could presumably enhance treatment response in PTSD.”
Quote in the paperSubstantial claim - Findingown data
OT administration enhanced amygdala reactivity in both male and female trauma-exposed controls.
“Notably, we found that OT enhanced amygdala reactivity in both male and female trauma-exposed controls.”
Quote in the paperSubstantial claim - Findingown data
PTSD patients with higher state anxiety under placebo showed more dampening of amygdala reactivity after OT administration.
“we found that PTSD patients, with higher state anxiety under placebo, showed more dampening of amygdala reactivity after OT administration.”
Quote in the paperSubstantial claim - Findingown data
In trauma-exposed controls, OT administration produced an overall enhancing effect on amygdala reactivity for all emotional faces.
“Notably, we found an overall amygdala enhancing effect, for all emotional faces, which may indicate generally enhanced processing of socially salient environmental cues”
Quote in the paperSubstantial claim - Findingcitation
Male PTSD patients had lower salivary OT levels than male trauma-exposed controls in the same sample.
“The notion that OT system functioning may be affected in PTSD patients is supported by our observation of lower salivary OT levels in male PTSD patients compared with male trauma-exposed controls (Frijling et al, 2015), in the same sample reported in this manuscript.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Frijling et al, 2015 source
Not checked in the free run.
- Interpretationown data
PTSD patients with higher state anxiety and hence higher left amygdala reactivity during placebo showed stronger dampening of amygdala reactivity after OT administration.
“indicating that PTSD patients with higher state anxiety and hence higher left amygdala reactivity during the placebo session showed stronger dampening of amygdala reactivity after OT administration.”
Quote in the paperSubstantial claim - Interpretationreasoning
The results indicate presumably beneficial neurobiological effects of OT administration in male and female PTSD patients.
“Taken together, our results indicate presumably beneficial neurobiological effects of OT administration in male and female PTSD patients.”
Quote in the paperSubstantial claim- Rests on an assumption: Dampened amygdala reactivity to emotional faces is beneficial in PTSD patients.
- Interpretationown data
Amygdala hyperresponsiveness may be a consequence of trauma exposure rather than of PTSD.
“Thus, amygdala hyperresponsiveness may be a consequence of trauma exposure rather than of PTSD.”
Quote in the paperSubstantial claim - Premisecitation
Oxytocin has anxiolytic properties.
“As the neuropeptide oxytocin (OT) has both anxiolytic (Heinrichs et al, 2003) and pro-social (Olff, 2012) properties”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Heinrichs et al, 2003 source
Not checked in the free run.
- Interpretationown data
In PTSD patients, OT administration abolished the association between left amygdala reactivity and anxiety prior to scanning.
“indicating that OT administration abolished the association between left amygdala reactivity and anxiety prior to scanning.”
Quote in the paperSubstantial claim - Premisecitation
About one third of PTSD patients responds poorly to currently available psychotherapies.
“Unfortunately, a third of patients responds poorly to currently available psychotherapies (Bradley et al, 2005), stressing the need for novel pharmacological interventions to enhance treatment response”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bradley et al, 2005 source
Not checked in the free run.
- Interpretationcitation
Dampening amygdala reactivity toward fearful stimuli in PTSD may be beneficial during exposure therapy.
“Dampening amygdala reactivity toward fearful stimuli in PTSD may be beneficial during exposure therapy.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: PTSD patients may benefit from improved fear regulation.
- Premisecitation
In PTSD, greater amygdala reactivity to fearful faces and negative pictures before treatment predicted worse treatment outcome.
“In PTSD, greater amygdala reactivity to fearful faces (Bryant et al, 2008) and negative pictures (van Rooij et al, 2015) before treatment predicted worse treatment outcome.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
OT system functioning may be affected in PTSD patients.
“The notion that OT system functioning may be affected in PTSD patients is supported by our observation of lower salivary OT levels in male PTSD patients compared with male trauma-exposed controls (Frijling et al, 2015), in the same sample reported in this manuscript.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frijling et al, 2015 source
Not checked in the free run.
- Premisecitation
Higher amygdala (and dACC and insula) reactivity toward negative emotional pictures prior to treatment predicted persistence of PTSD symptoms after treatment.
“In addition, higher amygdala (and dACC and insula) reactivity toward negative emotional pictures prior to treatment predicted persistence of PTSD symptoms after treatment (van Rooij et al, 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van Rooij et al, 2015 source
Not checked in the free run.
- Premisecitation
Greater amygdala reactivity toward fearful faces before treatment resulted in worse treatment outcome.
“greater amygdala reactivity toward fearful faces before treatment resulted in worse treatment outcome (Bryant et al, 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bryant et al, 2008 source
Not checked in the free run.
- Premisecitation
Greater amygdala reactivity during extinction learning is associated with impaired extinction learning.
“Greater amygdala reactivity during extinction learning has been associated with impaired extinction learning (Milad et al, 2009)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Milad et al, 2009 source
Not checked in the free run.
- Premisecitation
According to a meta-analysis, amygdala hyperactivity in PTSD patients was predominantly observed in response to negative, non-trauma-related stimuli.
“According to a meta-analysis of functional connectivity studies in PTSD, amygdala hyperactivity in PTSD patients was predominantly observed in response to negative, non-trauma-related stimuli (Hayes et al, 2012;Sripada et al, 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
OT administration effects may be especially beneficial in those who lack proficiency in fear regulation or social functioning.
“This fits with the hypothesis that OT administration effects may be especially beneficial in those who lack proficiency in fear regulation (Labuschagne et al, 2010) or social functioning (Olff et al, 2013;Weisman and Feldman, 2013).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Labuschagne et al, 2010 source
Not checked in the free run.
- cites Olff et al, 2013 source
Not checked in the free run.
- cites Weisman and Feldman, 2013 source
Not checked in the free run.
- The authors state this as an assumption: PTSD patients may benefit from improved fear regulation.
- Premisecitation
OT applied at higher doses, such as 40 IU used in this study, may result in anxiogenic effects in healthy individuals, owing to competitive binding to AVP receptors.
“Moreover, OT applied at higher doses (eg, 40 IU used in this study) may result in anxiogenic effects in healthy individuals, owing to competitive binding to argininevasopressin (AVP) receptors (Cardoso et al, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cardoso et al, 2013 source
Not checked in the free run.
- Interpretationown data
OT administration effects depend on inter-individual factors such as psychopathology and/or trauma exposure.
“Our findings underline previous observations that OT administration effects depend on inter-individual factors (eg, psychopathology and/ or trauma exposure).”
Quote in the paperSubstantial claim - Interpretationown data
PTSD patients with high anxiety prior to scanning and high baseline amygdala reactivity may especially benefit from OT administration.
“This indicates that PTSD patients with high anxiety prior to scanning and high baseline amygdala reactivity may especially benefit from OT administration.”
Quote in the paperSubstantial claim- The authors state this as an assumption: PTSD patients may benefit from improved fear regulation.
- Study design and conductreasoning
The study cannot exclude the possibility that not standardizing menstrual cycle phase may have influenced the results.
“We cannot exclude the possibility that this may have influenced our results, although similar effects of OT on amygdala reactivity previously were found in females tested in the follicular phase (Domes et al, 2010) and luteal phase (Bertsch et al, 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked
- May combine two claims. 15
- Classified as probably not a substantial claim. 26
May combine two claims.
Findingown dataIn PTSD patients, greater anxiety prior to scanning and amygdala reactivity during the placebo session were associated with greater reduction of amygdala reactivity after OT administration.
“In PTSD patients, greater anxiety prior to scanning and amygdala reactivity during the placebo session were associated with greater reduction of amygdala reactivity after OT administration.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn PTSD patients, the association between state anxiety and left amygdala reactivity under placebo was significant for happy-neutral faces but not for fearful-angry faces.
“The association between state anxiety and left amygdala reactivity was significant for reactivity toward happy-neutral faces (r = 0.412, p = 0.014), but not for reactivity toward fearful-angry faces (r = 0.274, p = 0.117).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe effects of OT on amygdala reactivity were independent of sex and stimulus valence.
“These effects of OT were independent of sex and stimulus valence (all P FWE 40.05).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOT administration effects on amygdala reactivity were lateralized to the left amygdala, with the same non-significant directionality in the right amygdala.
“Notably, OT administration effects were lateralized to the left amygdala, although the same (albeit non-significant) directionality of effects was observed in the right amygdala.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOT administration had opposite effects on amygdala reactivity in PTSD patients versus trauma-exposed controls: dampening in PTSD patients and enhancing in controls.
“Notably, we found opposite OT administration effects on amygdala reactivity in PTSD patients versus trauma-exposed controls (ie, dampening versus enhancing effects).”
- Also stated in: § FUNDING AND DISCLOSURE · plain
“OT administration resulted in dampened amygdala reactivity in PTSD patients and in enhanced amygdala reactivity in trauma-exposed controls.”
Quote in the paperSubstantial claim- Also stated in: § FUNDING AND DISCLOSURE · plain
May combine two claims.
Findingown dataUnder placebo, trauma-exposed controls showed differential activation toward fearful-angry faces compared with happy-neutral faces, whereas this effect was absent in PTSD patients.
“Under placebo, trauma-exposed controls showed differential activation toward fearful-angry faces compared with happy-neutral faces, whereas this effect was absent in PTSD patients.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe study was a randomized, double-blind, placebo-controlled, crossover fMRI study.
“This randomized, double-blind, placebo-controlled, crossover study consisted of three appointments: one intake session (T0) and two fMRI sessions (T1 and T2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOxytocin has pro-social properties.
“As the neuropeptide oxytocin (OT) has both anxiolytic (Heinrichs et al, 2003) and pro-social (Olff, 2012) properties”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Olff, 2012
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationOxytocin has been suggested as a promising pharmacological agent to enhance treatment response in PTSD.
“OT has been suggested as a promising pharmacological agent to enhance treatment response in PTSD (Koch et al, 2014;Olff et al, 2010).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationOT may have anxiolytic properties, possibly by inhibiting fear-associated output of the central amygdala to the brainstem and hypothalamus.
“Our findings extend accumulating evidence that OT may have anxiolytic properties, possibly by inhibiting fear-associated output of the central amygdala to the brainstem and hypothalamus (Huber et al, 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Huber et al, 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMedication order was counterbalanced between sessions.
“Medication order was counterbalanced between sessions.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationcitationAmygdala hyperactivity in PTSD may only become apparent during presentation of trauma-related stimuli and not during processing of non-trauma-related stimuli.
“Alternatively, amygdala hyperactivity in PTSD may only become apparent during presentation of trauma-related stimuli and not during processing of non-trauma-related stimuli (van Rooij et al, 2014), such as the emotional faces used in the present study.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van Rooij et al, 2014 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataTrauma-exposed controls were matched to PTSD patients based on age, sex, years of service, and educational level.
“Trauma-exposed male (n = 20) and female (n = 20) police officers were recruited via advertisements on websites and in journals of the Dutch police force and were matched to PTSD patients based on age, sex, number of years of service, and educational level.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStrength of therapeutic alliance is an important and consistent predictor of treatment success.
“Strength of therapeutic alliance, defined as the affective bond between the therapist and patient, is an important and consistent predictor of treatment success (Ormhaug et al, 2014)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ormhaug et al, 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationOT has been found to increase in-group trust, pro-social behavior and neural reward sensitivity to social stimuli in men and women.
“OT has been found to increase in-group trust, pro-social behavior and neural reward sensitivity to social stimuli in men and women (eg, Groppe et al, 2013;Van IJzendoorn and Bakermans-Kranenburg, 2012;Preckel et al, 2014;Striepens et al, 2014).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGreater amygdala reactivity during extinction learning in PTSD patients has been associated with impaired extinction recall the next day.
“Notably, greater amygdala reactivity during extinction learning in PTSD patients has been associated with impaired extinction recall the next day (Milad et al, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Milad et al, 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOT administration resulted in decreased subjective anxiety during a public speaking stressor in healthy individuals.
“Behaviorally, OT administration resulted in decreased subjective anxiety during a public speaking stressor in healthy individuals (de Oliveira et al, 2012) and increased (recall of) extinction learning in both rodents (Zoicas et al, 2014) and healthy males (Acheson et al, 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Oliveira et al, 2012 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTherapeutic alliance depends on the patient's attachment security: more secure attachment is related to stronger therapeutic alliance and vice-versa.
“and depends on the patient's attachment security: more secure attachment is related to stronger therapeutic alliance and vice-versa (see Diener and Monroe, 2011 for a metaanalysis).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Diener and Monroe, 2011 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationOT administration dampened amygdala reactivity toward emotional stimuli in healthy males, males with GSAD, and females with BPD, although findings for females have been mixed.
“In addition, functional MRI (fMRI) studies have shown that OT administration dampened amygdala reactivity toward emotional stimuli in healthy males (Kirsch et al, 2005), males with generalized social anxiety disorder (GSAD; Labuschagne et al, 2010) and females with borderline personality disorder (BPD; Bertsch et al, 2013), although findings for females have been mixed (Domes et al, 2010).”
Quote in the paperSubstantial claim0 of 3 sources checkedClassified as probably not a substantial claim.
InterpretationreasoningBy dampening excessive fear processing during exposure-based therapies, OT administration could result in enhanced treatment response.
“By dampening excessive fear processing during exposure-based therapies, OT administration could result in enhanced treatment response.”
Quote in the paperSubstantial claim- The authors state this as an assumption: PTSD patients may benefit from improved fear regulation.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationOT could potentially enhance motivation for treatment, as well as the therapeutic alliance.
“This way, OT could potentially enhance motivation for treatment, as well as the therapeutic alliance (Olff et al, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Olff et al, 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOT administration resulted in increased resting-state functional connectivity between the amygdala and vmPFC in healthy males and in patients with GSAD.
“Furthermore, OT administration resulted in increased resting-state functional connectivity between the amygdala and vmPFC in healthy males (Sripada et al, 2013) and in patients with GSAD (Dodhia et al, 2014), possibly enhancing top-down control over the fear response.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningPTSD patients may be less sensitive to OT administration, owing to alterations at the level of AVP and/or OT receptors, and therefore show dampened amygdala reactivity upon administration of this relatively high dose.
“PTSD patients, on the other hand, may be less sensitive to OT administration, owing to alterations at the level of AVP and/ or OT receptors, and therefore show dampened amygdala reactivity upon administration of this relatively high dose.”
Quote in the paperSubstantial claim- The authors state this as an assumption: PTSD patients may benefit from improved fear regulation.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA previous study showed elevated amygdala responses towards neutral pictures in PTSD patients compared with trauma-exposed controls.
“Indeed, a previous study showed elevated amygdala responses towards neutral pictures in PTSD patients compared with trauma-exposed controls (Brunetti et al, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brunetti et al, 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOT administration increased (recall of) extinction learning in rodents and healthy males.
“Behaviorally, OT administration resulted in decreased subjective anxiety during a public speaking stressor in healthy individuals (de Oliveira et al, 2012) and increased (recall of) extinction learning in both rodents (Zoicas et al, 2014) and healthy males (Acheson et al, 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEffective exposure therapy was associated with decreased amygdala and enhanced vmPFC activity toward emotional faces over the course of treatment.
“In addition, effective exposure therapy was associated with decreased amygdala and enhanced vmPFC activity toward emotional faces over the course of treatment (Felmingham et al, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Felmingham et al, 2010 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe prevailing neurocircuitry model of PTSD postulates amygdala hyperactivity and vmPFC hypoactivity toward both trauma-related and non-trauma-related stimuli.
“The prevailing neurocircuitry model of PTSD postulates amygdala hyperactivity and ventromedial prefrontal cortex (vmPFC) hypoactivity toward both trauma-related and non-trauma-related stimuli (Pitman et al, 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pitman et al, 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationIn healthy individuals, OT effects seem to follow an inverted u-shape, with doses around 24 IU resulting in more anxiolytic effects than higher doses.
“In healthy individuals, OT effects seem to follow an inverted u-shape (Rilling et al, 2014), with doses ~24 IU, resulting in more anxiolytic effects than higher doses of OT (Cardoso et al, 2013).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningPTSD patients may be specifically sensitive to show greater amygdala responsiveness to the neutral, socially ambiguous faces in the happy-neutral condition.
“Possibly, PTSD patients may be specifically sensitive to show greater amygdala responsiveness to the neutral, socially ambiguous faces in the happy-neutral condition.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInsecure attachment has been associated with higher PTSD symptom severity in trauma-exposed individuals.
“Attachment style may be particularly relevant in PTSD: insecure attachment, has been associated with higher PTSD symptom severity in trauma-exposed individuals (see Woodhouse et al, 2015 a meta-analysis).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Woodhouse et al, 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study included females using oral contraceptives.
“First, we included females using oral contraceptives.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningTo control for potential confounding by trauma exposure, the study included a trauma-exposed sample of police officers without PTSD, limiting generalizability.
“At last, to control for the potential confounding effect of trauma exposure, we included a trauma-exposed sample of police officers without PTSD, limiting the generalizability of our findings.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPerception of attachment security was improved after OT administration in healthy male students.
“Notably, perception of attachment security was improved after OT administration in healthy male students (Buchheim et al, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Buchheim et al, 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe study did not standardize the phase of menstrual cycle of female participants.
“Also, we did not standardize the phase of menstrual cycle our female participants were scanned in, to minimize time and hence potential differences in symptom severity between the two scanning sessions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study was registered in the Netherlands Trial Registry (NTR3516).
“Registered in the Netherlands Trial Registry (number: NTR3516)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnxiously attached healthy males remembered their mother as less caring after OT administration, compared with placebo.
“However, opposite effects of OT administration on attachment have also been found: anxiously attached healthy males remembered their mother as less caring after OT administration, compared with placebo (Bartz et al, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bartz et al, 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOT administration in anxiously attached BPD patients and healthy controls decreased cooperation and trust.
“In addition, OT administration in anxiously attached BPD patients and healthy controls decreased cooperation and trust (Bartz et al, 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bartz et al, 2011 source
Not checked in the free run.
The paper relies on this without support.
Dampened amygdala reactivity to emotional faces is beneficial in PTSD patients.
“Taken together, our results indicate presumably beneficial neurobiological effects of OT administration in male and female PTSD patients.”
The paper relies on this without support.
Trauma-exposed police officers without PTSD are an appropriate control group to account for trauma exposure and isolate PTSD-related effects.
“We included a highly traumaexposed control group to account for potential confounding effects of trauma exposure on neurobiology.”
The paper relies on this without support.
This is the first study investigating neurobiological effects of OT administration in PTSD patients.
“To our knowledge, this is the first study investigating neurobiological effects of OT administration in PTSD patients, as a first step to show the potential clinical importance of OT administration in PTSD patients.”
The authors state this as an assumption.
Trauma-exposed controls had little to gain regarding fear regulation.
“Presumably, our trauma-exposed controls did have little to gain regarding fear regulation”
The authors state this as an assumption.
PTSD patients may benefit from improved fear regulation.
“whereas PTSD patients may benefit from improved fear regulation.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recent neuroimaging studies have reported oxytocin-induced increases in neural activation in regions, including the amygdala, which are associated with processing of salience and arousal.
“These studies have reported oxytocin-induced increases in neural activation in regions, including the amygdala, which are associated with processing of salience and arousal (Frijling et al., 2016;Gorka et al., 2015;Koch et al., 2016).”
From Meta-analytic review of the effects of a single dose of intranasal oxytocin on threat processing in humans (2018) · cites this paper as Koch et al., 2016
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Inconsistent p-value: t(39) = -2.18,p = .037
MinorThe paper reports p = .037 here; recomputing from the test statistic and its degrees of freedom gives p = .035 (two-tailed). The check cannot tell whether the statistic or the p-value is the misprint.
Reported p = .037 · recomputed p = .035
“t(39) = -2.18,p = 0.037”
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upt(39) = -2.18reported p = .037 · recomputed p = .035
“t(39) = -2.18,p = .037”
- Consistentt(34) = 2.114reported p = .042 · recomputed p = .042
“t(34) = 2.114, p = .042”
- ConsistentF(1, 39) = 0.656reported p = .423 · recomputed p = .423
“F(1,39) = 0.656, p = .423”
- ConsistentF(1, 34) = 0.998reported p = .325 · recomputed p = .325
“F(1,34) = 0.998, p = .325”
- ConsistentF(1, 34) = 0.261reported p = .613 · recomputed p = .613
“F(1,34) = 0.261, p = .613”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
PTSD subgroup counts exceed the table total
MinorTable 1 labels the PTSD group as 36 patients, but its male and female counts sum to 37.
Reported 36 · recomputed 37
“PTSD patients (n = 36) Healthy controls (n = 40) Statistics Males (n = 21) Females (n = 16)”
Female control education percentage is incorrect
MinorThe table reports 17 of 20 female controls in the middle education category as 90%; that fraction is 85%. The remaining 3 of 20 are likewise 15%, not the reported 10%.
Reported 90 · recomputed 85
“Males (n = 20) Females (n = 20) Males Females Age, in years 42.29 (9.83) 37.56 (9.78) 41.35 (10.62) 38.65 (9.48) t(39) = -0.293p = 0.771 t(34) = 0.337 p = 0.738 Years of service 16.29 (10.82) 14.53 (10.74) 18.42 (10.05) 18.60 (9.84) t(39) = 0.655 p = 0.516 t(33) = 1.163 p = 0.253 Educational level Low 0 (0%) 0 (0%) 0 (0%) 0 (0%) χ 2 = 0.006 χ 2 = 1.694Middle 14 (67%) 15 (93%) 16 (85%) 17 (90%)”
Emotion-block count is stated two ways
MinorThe methods say there were four blocks of each of two emotion conditions, but then specify two blocks of each condition-four emotion blocks in total.
“Four blocks of each emotion condition were presented, two with fearful-angry faces and two with happy-neutral faces.”
“The first emotion condition consisted of fearful and angry faces and the second emotion condition consisted of happy and neutral faces.”
Male control education percentage is incorrect
MinorThe table reports 16 of 20 male controls in the middle education category as 85%; that fraction is 80%. The remaining 4 of 20 are likewise 20%, not the reported 15%.
Reported 85 · recomputed 80
“Males (n = 20) Females (n = 20) Males Females Age, in years 42.29 (9.83) 37.56 (9.78) 41.35 (10.62) 38.65 (9.48) t(39) = -0.293p = 0.771 t(34) = 0.337 p = 0.738 Years of service 16.29 (10.82) 14.53 (10.74) 18.42 (10.05) 18.60 (9.84) t(39) = 0.655 p = 0.516 t(33) = 1.163 p = 0.253 Educational level Low 0 (0%) 0 (0%) 0 (0%) 0 (0%) χ 2 = 0.006 χ 2 = 1.694Middle 14 (67%) 15 (93%) 16 (85%)”
Valence-dependent reactivity was not absent in both amygdalae
MinorThe abstract states without qualification that valence-dependent amygdala reactivity was absent in PTSD patients. The results instead report significantly greater right-amygdala activity for fearful-angry than happy-neutral faces in those patients; only the left-amygdala difference was absent.
“Under placebo, the expected valence-dependent amygdala reactivity (ie, greater activity toward fearful-angry faces compared with happy-neutral faces) was absent in PTSD patients.”
“Right amygdala activity was significantly higher during fearful-angry compared with happy-neutral faces both in trauma-exposed controls (P FWE o0.001) and PTSD patients (P FWE = 0.005).”
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
(1970) · Cited by 24,983 · see citing works
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
(1998) · PubMed · Cited by 10,216 · see citing works
Dissociable intrinsic connectivity networks for salience processing and executive control
Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., Reiss, A. L., & Greicius, M. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5587-06.2007 · Cited by 7,426 · see citing works
Introduction to mediation, moderation, and conditional process analysis :
Hayes, A. F., & names (2015) · Cited by 7,004 · see citing works
The development of a Clinician-Administered PTSD Scale
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995) · Journal of Traumatic Stress · doi:10.1002/jts.2490080106 · Cited by 5,024 · see citing works
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · see citing works
A differential neural response in the human amygdala to fearful and happy facial expressions
Morris, J. S., Frith, C. D., Perrett, D. I., Rowland, D., Young, A. W., Calder, A. J., & Dolan, R. J. (1996) · Nature · doi:10.1038/383812a0 · Cited by 2,013 · see citing works
A Multidimensional Meta-Analysis of Psychotherapy for PTSD
Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.214 · Cited by 1,938 · see citing works
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639 · see citing works
Biological studies of post-traumatic stress disorder
Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3339 · Cited by 1,529 · see citing works
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.004 · Cited by 1,397 · see citing works
Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder
Milad, M. R., Pitman, R. K., Ellis, C. B., Gold, A. L., Shin, L. M., Lasko, N. B., Zeidan, M. A., Handwerger, K., Orr, S. P., & Rauch, S. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.026 · Cited by 1,339 · see citing works
The Amygdala Response to Emotional Stimuli: A Comparison of Faces and Scenes
Hariri, A. R., Tessitore, A., Mattay, V. S., Fera, F., & Weinberger, D. R. (2002) · NeuroImage · doi:10.1006/nimg.2002.1179 · Cited by 984 · see citing works
Albeck, J. H. (2001) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.2001.55.2.295 · Cited by 973 · see citing works
Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804 · see citing works
Oxytocin attenuates amygdala responses to emotional faces regardless of valence
Domes, G., Heinrichs, M., Gläscher, J., Büchel, C., Braus, D. F., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.025 · Cited by 774 · see citing works
Olff, M., Frijling, J. L., Kubzansky, L. D., Bradley, B., Ellenbogen, M. A., Cardoso, C., Bartz, J. A., Yee, J. R., & van Zuiden, M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.019 · Cited by 620 · see citing works
Self-citationPsychometric properties of the Early Trauma Inventory-Self Report
Bremner, J. D., Bolus, R., & Mayer, E. A. (2007) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000243824.84651.6c · Cited by 550 · see citing works
Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder
Labuschagne, I., Phan, K. L., Wood, A., Angstadt, M., Chua, P., Heinrichs, M., Stout, J. C., & Nathan, P. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.123 · Cited by 549 · see citing works
Patel, R., Spreng, R. N., Shin, L. M., & Girard, T. A. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.003 · Cited by 546 · see citing works
Effects of intranasal oxytocin on emotional face processing in women
Domes, G., Lischke, A., Berger, C., Grossmann, A., Hauenstein, K., Heinrichs, M., & Herpertz, S. C. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.016 · Cited by 521 · see citing works
Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans
Gamer, M., Zurowski, B., & Büchel, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000985107 · Cited by 487 · see citing works
Processing of the arousal of subliminal and supraliminal emotional stimuli by the human amygdala
Gläscher, J., & Adolphs, R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10274.2003 · Cited by 457 · see citing works
Applying Learning Principles to the Treatment of Post‐Trauma Reactions
ROTHBAUM, B. O., & DAVIS, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1301.012 · Cited by 454 · see citing works
Oxytocin can hinder trust and cooperation in borderline personality disorder
Bartz, J., Simeon, D., Hamilton, H., Kim, S., Crystal, S., Braun, A., Vicens, V., & Hollander, E. (2011) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsq085 · Cited by 452 · see citing works
Quantitative meta-analysis of neural activity in posttraumatic stress disorder
Hayes, J. P., Hayes, S. M., & Mikedis, A. M. (2012) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-2-9 · Cited by 452 · see citing works
Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity
Petrovic, P., Kalisch, R., Singer, T., & Dolan, R. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4572-07.2008 · Cited by 424 · see citing works
The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands
de Vries, G., & Olff, M. (2009) · Journal of Traumatic Stress · doi:10.1002/jts.20429 · Cited by 390 · see citing works
Self-citationVan IJzendoorn, M. H., & Bakermans-Kranenburg, M. J. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.008 · Cited by 365 · see citing works
Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder
Sripada, R. K., King, A. P., Garfinkel, S. N., Wang, X., Sripada, C. S., Welsh, R. C., & Liberzon, I. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110069 · Cited by 352 · see citing works
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Chen, X., Gautam, P., Stair, S., Haroon, E., Thompson, R., Ditzen, B., Patel, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.022 · Cited by 343 · see citing works
Bryant, R. A., Felmingham, K., Kemp, A., Das, P., Hughes, G., Peduto, A., & Williams, L. (2008) · Psychological Medicine · doi:10.1017/s0033291707002231 · Cited by 307 · see citing works
Oxytocin enhances the experience of attachment security
Buchheim, A., Heinrichs, M., George, C., Pokorny, D., Koops, E., Henningsen, P., O’Connor, M.-F., & Gündel, H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.002 · Cited by 277 · see citing works
Diener, M. J., & Monroe, J. M. (2011) · Psychotherapy · doi:10.1037/a0022425 · Cited by 260 · see citing works
Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder
Domes, G., Heinrichs, M., Kumbier, E., Grossmann, A., Hauenstein, K., & Herpertz, S. C. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.007 · Cited by 255 · see citing works
Effects of oxytocin on recollections of maternal care and closeness
Bartz, J. A., Zaki, J., Ochsner, K. N., Bolger, N., Kolevzon, A., Ludwig, N., & Lydon, J. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012669107 · Cited by 235 · see citing works
Groppe, S. E., Gossen, A., Rademacher, L., Hahn, A., Westphal, L., Gründer, G., & Spreckelmeyer, K. N. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.023 · Cited by 218 · see citing works
Bertsch, K., Gamer, M., Schmidt, B., Schmidinger, I., Walther, S., Kästel, T., Schnell, K., Büchel, C., Domes, G., & Herpertz, S. C. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020263 · Cited by 214 · see citing works
The relationship between adult attachment style and post-traumatic stress symptoms: A meta-analysis
Woodhouse, S., Ayers, S., & Field, A. P. (2015) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.07.002 · Cited by 210 · see citing works
Dodhia, S., Hosanagar, A., Fitzgerald, D. A., Labuschagne, I., Wood, A. G., Nathan, P. J., & Phan, K. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.53 · Cited by 209 · see citing works
Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex
Sripada, C. S., Phan, K. L., Labuschagne, I., Welsh, R., Nathan, P. J., & Wood, A. G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000533 · Cited by 197 · see citing works
Oxytocin increases amygdala reactivity to threatening scenes in females
Lischke, A., Gamer, M., Berger, C., Grossmann, A., Hauenstein, K., Heinrichs, M., Herpertz, S. C., & Domes, G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.01.011 · Cited by 194 · see citing works
Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum
Zoicas, I., Slattery, D. A., & Neumann, I. D. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.156 · Cited by 189 · see citing works
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study
Cardoso, C., Ellenbogen, M. A., Orlando, M. A., Bacon, S. L., & Joober, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.013 · Cited by 187 · see citing works
Paloyelis, Y., Doyle, O. M., Zelaya, F. O., Maltezos, S., Williams, S. C., Fotopoulou, A., & Howard, M. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.005 · Cited by 187 · see citing works
Felmingham, K., Williams, L. M., Kemp, A. H., Liddell, B., Falconer, E., Peduto, A., & Bryant, R. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0017551 · Cited by 179 · see citing works
Domes, G., Kumbier, E., Heinrichs, M., & Herpertz, S. C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.254 · Cited by 160 · see citing works
Anxiolytic-like effect of oxytocin in the simulated public speaking test
de Oliveira, D. C., Zuardi, A. W., Graeff, F. G., Queiroz, R. H., & Crippa, J. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111400642 · Cited by 154 · see citing works
Acheson, D., Feifel, D., de Wilde, S., Mckinney, R., Lohr, J., & Risbrough, V. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3099-4 · Cited by 141 · see citing works
A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder
Olff, M., Langeland, W., Witteveen, A., & Denys, D. (2010) · CNS Spectrums · doi:10.1017/s109285290000047x · Cited by 135 · see citing works
Self-citationBonding after trauma: on the role of social support and the oxytocin system in traumatic stress
Olff, M. (2012) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v3i0.18597 · Cited by 131 · see citing works
Self-citationKoch, S. B. J., van Zuiden, M., Nawijn, L., Frijling, J. L., Veltman, D. J., & Olff, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.018 · Cited by 123 · see citing works
Self-citationvan Rooij, S. J. H., Kennis, M., Vink, M., & Geuze, E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.257 · Cited by 122 · see citing works
Ormhaug, S. M., Jensen, T. K., Wentzel-Larsen, T., & Shirk, S. R. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0033884 · Cited by 113 · see citing works
Oxytocin facilitates social approach behavior in women
Preckel, K., Scheele, D., Kendrick, K. M., Maier, W., & Hurlemann, R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00191 · Cited by 111 · see citing works
Brunetti, M., Sepede, G., Mingoia, G., Catani, C., Ferretti, A., Merla, A., Del Gratta, C., Romani, G. L., & Babiloni, C. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.024 · Cited by 101 · see citing works
Frijling, J. L., van Zuiden, M., Nawijn, L., Koch, S. B. J., Neumann, I. D., Veltman, D. J., & Olff, M. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12300 · Cited by 74 · see citing works
Self-citationStriepens, N., Matusch, A., Kendrick, K. M., Mihov, Y., Elmenhorst, D., Becker, B., Lang, M., Coenen, H. H., Maier, W., Hurlemann, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.026 · Cited by 71 · see citing works
Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review
de Kleine, R. A., ROTHBAUM, B. O., & van Minnen, A. (2013) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v4i0.21626 · Cited by 67 · see citing works
Pharmacological Innovations for Posttraumatic Stress Disorder and Medication- Enhanced Psychotherapy
Dunlop, B. W., Mansson, E. E., & Gerardi, M. A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803530899 · Cited by 48 · see citing works
Neural correlates of trauma-unrelated emotional processing in war veterans with PTSD
van Rooij, S. J. H., Rademaker, A. R., Kennis, M., Vink, M., Kahn, R. S., & Geuze, E. (2015) · Psychological Medicine · doi:10.1017/s0033291714001706 · Cited by 36 · see citing works
Oxytocin Effects on the Human Brain: Findings, Questions, and Future Directions
Weisman, O., & Feldman, R. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.026 · Cited by 22 · see citing works
Flagged first, then by citations
1 of the 66 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Carlier I, Gersons B (1992). Development of a scale for traumatic incidents in police work. Psychiatr Fenn 23: 59–70.
- First MB, Spitzer RL, Gibbon M, Williams JB (2012) Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. American Psychiatric Publishing Inc.: Arlington, VA.
- van Groenestijn M, Akkerhuis G, Kupka R, Schneider N, Nolen W (1999) Gestructureerd Klinisch Interview voor de vaststelling van DSM-IV As 1 Stoornissen [Dutch translation of the SCID-I/P]. Zwets & Zeitlinger: Lisse, the Netherlands.
Cited by
Sorted by citations
Understanding resilience: New approaches for preventing and treating PTSD
Horn, S. R. G.-V., Charney, D. S., & Feder, A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.002 · Cited by 223 · see citing works
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Burback, L., Brémault‐Phillips, S., Nijdam, M. J., McFARLANE, A. C., & Vermetten, E. H. G. J. M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230428091433 · Cited by 232 · see citing works
Meta-analysis of the effects of intranasal oxytocin on interpretation and expression of emotions
Leppanen, J., Ng, K. W., Tchanturia, K., & Treasure, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.010 · Cited by 188 · see citing works
Careaga, M. B. L., Girardi, C. E. N., & Suchecki, D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.023 · Cited by 181 · see citing works
Role of social cognition in post-traumatic stress disorder: a review and meta-analysis.
Stevens, J. S., & Jovanovic, T. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12518 · Cited by 139 · see citing works
Intranasal Oxytocin Normalizes Amygdala Functional Connectivity in Posttraumatic Stress Disorder
Koch, S. B. J., van Zuiden, M., Nawijn, L., Frijling, J. L., Veltman, D. J., & Olff, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.1 · Cited by 132 · see citing works
Self-citationvan Zuiden, M., Frijling, J. L., Nawijn, L., Koch, S. B. J., Goslings, J. C., Luitse, J. S., Biesheuvel, T. H., Honig, A., Veltman, D. J., & Olff, M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.11.012 · Cited by 134 · see citing works
Self-citationSex differences in fear extinction
Velasco, E. R., Florido, A., Milad, M. R., & Andero, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.020 · Cited by 125 · see citing works
Grace, S. A., Rossell, S. L., Heinrichs, M., Kordsachia, C., & Labuschagne, I. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.031 · Cited by 120 · see citing works
The Associations Between Oxytocin and Trauma in Humans: A Systematic Review
Donadon, M. F., Martín‐Santos, R., & Osório, F. D. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00154 · Cited by 119 · see citing works
RDoC-based categorization of amygdala functions and its implications in autism
Hennessey, T., Andari, E., & Rainnie, D. G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.007 · Cited by 105 · see citing works
Oxytocin and stress-related disorders: neurobiological mechanisms and treatment opportunities
Sippel, L. M., Allington, C. E., Pietrzak, R. H., Harpaz-Rotem, I., Mayes, L. C., & Olff, M. (2017) · Chronic Stress · doi:10.1177/2470547016687996 · Cited by 99 · see citing works
Self-citationWang, D., Yan, X., Li, M., & Ma, Y. (2017) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsx085 · Cited by 86 · see citing works
Frijling, J. L. (2017) · European Journal of Psychotraumatology · doi:10.1080/20008198.2017.1302652 · Cited by 84 · see citing works
Self-citationHelpman, L., Zhu, X., Suarez-Jimenez, B., Lazarov, A., Monk, C., & Neria, Y. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0854-y · Cited by 82 · see citing works
Koch, S. B. J., van Zuiden, M., Nawijn, L., Frijling, J. L., Veltman, D. J., & Olff, M. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160129 · Cited by 80 · see citing works
Self-citationPeled‐Avron, L., Abu-Akel, A. M., & Shamay‐Tsoory, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.023 · Cited by 73 · see citing works
Intranasal oxytocin increases neural responses to social reward in post-traumatic stress disorder
Nawijn, L., van Zuiden, M., Koch, S. B. J., Frijling, J. L., Veltman, D. J., & Olff, M. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw123 · Cited by 72 · see citing works
Self-citationKhalili‐Mahani, N., Rombouts, S. A. R. B., van Osch, M. J. P., Duff, E. P., Carbonell, F., Nickerson, L. D. H., Becerra, L. R., Dahan, A., Evans, A. C., Soucy, J., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23516 · Cited by 61 · see citing works
Posttraumatic Stress Disorder and Anxiety-Related Conditions
Williamson, J. B., Jaffee, M. S., & Jorge, R. E. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001054 · Cited by 66 · see citing works
Kou, J., Zhang, Y., Zhou, F., Sindermann, C., Montag, C., Becker, B., & Kendrick, K. M. (2020) · Psychological Medicine · doi:10.1017/s0033291720003803 · Cited by 63 · see citing works
Frijling, J. L., van Zuiden, M., Koch, S. B. J., Nawijn, L., Veltman, D. J., & Olff, M. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsv116 · Cited by 62 · see citing works
Self-citationNawijn, L., van Zuiden, M., Koch, S. B. J., Frijling, J. L., Veltman, D. J., & Olff, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.020 · Cited by 59 · see citing works
Self-citationKraaijenvanger, E. J., He, Y., Spencer, H., Smith, A. K., Bos, P. A., & Boks, M. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.016 · Cited by 57 · see citing works
Smith, N. B., Doran, J. M., Sippel, L. M., & Harpaz-Rotem, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.006 · Cited by 46 · see citing works
Leppanen, J., Ng, K. W., Kim, Y.-R., Tchanturia, K., & Treasure, J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.041 · Cited by 45 · see citing works
Female psychopharmacology matters! Towards a sex-specific psychopharmacology
Bolea-Alamanac, B. M., Bailey, S., Lovick, T. A., Scheele, D., & Valentino, R. J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117747578 · Cited by 44 · see citing works
Koch, S. B. J., van Zuiden, M., Nawijn, L., Frijling, J. L., Veltman, D. J., & Olff, M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.002 · Cited by 45 · see citing works
Self-citationBose, M., Quipildor, G. F., Ehrlich, M. E., & Salton, S. R. (2022) · Cells · doi:10.3390/cells11223629 · Cited by 44 · see citing works
Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects
Naja, W., & Aoun, M. P. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0819-1 · Cited by 40 · see citing works
The impact of sex as a biological variable in the search for novel antidepressants
Williams, A. V., & Trainor, B. C. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.05.003 · Cited by 40 · see citing works
PTSD: Past, present and future implications for China
Zhou, Y., Shang, Z., Zhang, F., Wu, L., Sun, L., Jia, Y., Yu, H., & Liu, W. (2021) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2021.04.011 · Cited by 41 · see citing works
Quintana, D. S., Dieset, I., Elvsåshagen, T., Westlye, L. T., & Andreassen, O. A. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.12.004 · Cited by 39 · see citing works
Huebner, B., & Schulkin, J. A. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108982191 · Cited by 37 · see citing works
Oxytocin receptor gene methylation in male and female PTSD patients and trauma-exposed controls
Nawijn, L., Krzyzewska, I. M., van Zuiden, M., Henneman, P., Koch, S. B. J., Mul, A. N. P. M., Frijling, J. L., Veltman, D. J., Mannens, M. M. A. M., & Olff, M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.10.006 · Cited by 38 · see citing works
Self-citationVariation in the oxytocin receptor gene (OXTR) is associated with differences in moral judgment
Bernhard, R. M., Chaponis, J., Siburian, R., Gallagher, P., Ransohoff, K. J., Wikler, D. I., Perlis, R. H., & Greene, J. D. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw103 · Cited by 38 · see citing works
Tully, J., Gabay, A. S., Brown, D., Murphy, D., & Blackwood, N. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.11.017 · Cited by 37 · see citing works
Decreased Plasma Oxytocin Levels in Patients With PTSD
Carmassi, C., Marazziti, D., Mucci, F., Vecchia, A. D., Barberi, F. M., Baroni, S., Giannaccini, G., Palego, L., Massimetti, G., & Dell’Osso, L. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.612338 · Cited by 36 · see citing works
Iffland, B., & Neuner, F. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00732 · Cited by 33 · see citing works
Gasparyan, A., Navarro, D., Navarrete, F., & Manzanares, J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109211 · Cited by 32 · see citing works
Baron-Cohen, K. L., Feldman, R., Fearon, P. R. M., & Fonagy, P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.062 · Cited by 30 · see citing works
Witteveen, A. B., Stramrood, C. A. I., Henrichs, J., Flanagan, J. C., van Pampus, M. G., & Olff, M. (2019) · Archives of Women s Mental Health · doi:10.1007/s00737-019-00994-0 · Cited by 29 · see citing works
Self-citationDavis, L. L., & Hamner, M. B. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1356563 · Cited by 32 · see citing works
The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders
Jin, Y., Song, D. F., Yan, Y., Quan, Z., & Qing, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310430 · Cited by 30 · see citing works
Genetic variant in CACNA1C is associated with PTSD in traumatized police officers
Krzyzewska, I., Ensink, J., Nawijn, L., Mul, A., Koch, S., Venema, A., Shankar, V., Frijling, J., Veltman, D., Lindauer, R., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-017-0059-1 · Cited by 25 · see citing works
Self-citationSakamoto, T., Sugimoto, S., & Uekita, T. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112701 · Cited by 25 · see citing works
Jeung-Maarse, H., Schmitgen, M. M., Schmitt, R., Bertsch, K., & Herpertz, S. C. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01549-9 · Cited by 26 · see citing works
Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic‐Pituitary‐Adrenal Axis
Borrow, A. P., Stranahan, A. M., Suchecki, D., & Yunes, R. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12403 · Cited by 26 · see citing works
van Zuiden, M., Savas, M., Koch, S. B. J., Nawijn, L., Staufenbiel, S. M., Frijling, J. L., Veltman, D. J., van Rossum, E. F. C., & Olff, M. (2019) · Journal of Traumatic Stress · doi:10.1002/jts.22395 · Cited by 25 · see citing works
Self-citationFlanagan, J. C., Sippel, L. M., Maria, M. M. M., Hartwell, K. J., Brady, K. T., & Joseph, J. E. (2019) · European Journal of Psychotraumatology · doi:10.1080/20008198.2019.1606626 · Cited by 27 · see citing works
Liu, C., Lan, C., Li, K., Zhou, F., Yao, S., Xu, L., Yang, N., Zhou, X., Yang, J., Yong, X., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.04.009 · Cited by 23 · see citing works
Crane, J. W., Holmes, N. M., Fam, J. P., Westbrook, R. F., & Delaney, A. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00571.2019 · Cited by 23 · see citing works
Oxytocin increases eye gaze in schizophrenia
Bradley, E. R., Seitz, A., Niles, A. N., Rankin, K. P., Mathalon, D. H., O'Donovan, A., & Woolley, J. D. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.039 · Cited by 22 · see citing works
Alvarez-Ricartes, N., Oliveros-Matus, P., Mendoza, C., Perez-Urrutia, N., Echeverria, F., Iarkov, A., Barreto, G. E., & Echeverrı́a, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0916-0 · Cited by 21 · see citing works
Woodward, S. H., Jamison, A. L., Gala, S., & Holmes, T. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179912 · Cited by 21 · see citing works
Sippel, L. M., Flanagan, J. C., Holtzheimer, P. E., Maria, M. M. M., Brady, K. T., & Joseph, J. E. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111368 · Cited by 21 · see citing works
Sherman, B. J., Baker, N. L., Brady, K. T., Joseph, J. E., Nunn, L. M., & McRae‐Clark, A. L. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05516-w · Cited by 19 · see citing works
Oxytocin, Vasopressin and Stress: A Hormetic Perspective
Nazarloo, H. P., Kingsbury, M. A., Lamont, H., Dale, C. V., Nazarloo, P., Davis, J. M., Porges, E. C., Cuffe, S. P., & Carter, C. S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080632 · Cited by 19 · see citing works
H2S and Oxytocin Systems in Early Life Stress and Cardiovascular Disease
McCook, O., Denoix, N., Radermacher, P., Waller, C., & Merz, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163484 · Cited by 16 · see citing works
Neuroendocrinological treatment targets for posttraumatic stress disorder
Yoon, S., & Kim, Y. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.021 · Cited by 18 · see citing works
Marazziti, D., Diep, P.-T., Carter, C. S., & Carbone, M. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220727120646 · Cited by 16 · see citing works
Procyshyn, T. L., Lombardo, M. V., Lai, M., Jassim, N., Bonnie Auyeung, B., Crockford, S. K., Deakin, J., Soubramanian, S., Sule, A., Terburg, D., et al. (2022) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsac016 · Cited by 14 · see citing works
Yu, Y., Yu, H., Babygirija, R., Shi, B., Sun, W., Zheng, X., & Zheng, J. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19065 · Cited by 12 · see citing works
Arizmendi, B. J., Seeley, S. H., Allen, J. J. B., Killgore, W. D. S., Andrews‐Hanna, J. R., Weihs, K. L., & O'Connor, M. (2023) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2023.100339 · Cited by 10 · see citing works
Thomaes, K., de Kloet, C. S., Wilker, S., El‐Hage, W., Schäfer, I., Kleim, B., Schmahl, C. G., & van Zuiden, M. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.29453 · Cited by 10 · see citing works
Functional neuro-anatomy of social cognition in posttraumatic stress disorder: A systematic review
Couette, M., Mouchabac, S., Adrien, V., Cagnone, V., Bourla, A., & Ferreri, F. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114729 · Cited by 9 · see citing works
Maslahati, T., Wingenfeld, K., Hellmann‐Regen, J., Kraft, J., Lyu, J., Keinert, M., Voß, A. L., Cho, A. B., Ripke, S., Otte, C., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02339-z · Cited by 9 · see citing works
Intranasal oxytocin attenuates insula activity in response to dynamic angry faces
Ma, Y., Ran, G., Hu, N., Hu, Y., Long, W., & Chen, X. (2020) · Biological Psychology · doi:10.1016/j.biopsycho.2020.107976 · Cited by 9 · see citing works
Lotfinia, S., Afshar, A., Yaseri, A., Olff, M., & Quidé, Y. (2023) · Brain and Behavior · doi:10.1002/brb3.3292 · Cited by 7 · see citing works
Self-citationTrauma occurs in social contexts
Sijbrandij, M., & Olff, M. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.31389 · Cited by 8 · see citing works
Self-citationPotential role of oxytocin in the regulation of memories and treatment of memory disorders
Walia, V., Wal, P., Mishra, S., Agrawal, A., Kosey, S., & Patil, A. D. (2024) · Peptides · doi:10.1016/j.peptides.2024.171222 · Cited by 8 · see citing works
Zhao, W., Zhang, X., & Kendrick, K. M. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106624 · Cited by 7 · see citing works
Kreutzmann, J. C., & Fendt, M. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100313 · Cited by 6 · see citing works
Clinical Outcomes of Severe Forms of Early Social Stress
Berhe, O., Gerhardt, S., & Schmahl, C. G. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_261 · Cited by 6 · see citing works
Liu, P., Lin, T., Fischer, H., Feifel, D., & Ebner, N. C. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110130 · Cited by 5 · see citing works
Johnston, M. P., & Wanat, M. J. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1038236 · Cited by 6 · see citing works
van Sleeuwen, C., van Zuiden, M., Koch, S. B. J., Frijling, J. L., Veltman, D. J., Olff, M., & Nawijn, L. (2023) · European Journal of Psychotraumatology · doi:10.1080/20008066.2023.2281187 · Cited by 6 · see citing works
Self-citationPreckel, K., Trautmann, S., & Kanske, P. (2021) · Clinical Psychology in Europe · doi:10.32872/cpe.3645 · Cited by 5 · see citing works
Influence of intranasal oxytocin on fear consolidation in healthy humans
Hoge, E. A., Bui, É., Rosencrans, P. L., Orr, S. P., Ross, R., Ojserkis, R. A., & Simon, N. M. (2019) · General Psychiatry · doi:10.1136/gpsych-2019-100131 · Cited by 4 · see citing works
Ma, Y., Liu, G., Hu, Y., & Long, W. (2021) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.12.003 · Cited by 4 · see citing works
Main Biological Models of Resilience.
Marazziti, D., Fantasia, S., Palermo, S., Arone, A., Massa, L., Gambini, M., & Carmassi, C. (2024) · PubMed Central · doi:10.36131/cnfioritieditore20240201 · Cited by 5 · see citing works
Gryksa, K., Schmidtner, A. K., Schäfer, T., Reber, S. O., & Neumann, I. D. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106104 · Cited by 3 · see citing works
Moshfeghinia, R., Sanaei, E., Kavari, K., Barzegari, A. M., Ahmadzadeh, A. M., Bafrani, M. A., Habibzadeh, A., Boroon, M., & Shalbafan, M. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00996-y · Cited by 4 · see citing works
Sorenson, K., Kendall, E., Grell, H., Kang, M., Shaffer, C. L., & Hwang, S. (2023) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20230008 · Cited by 3 · see citing works
Huang, Q., Zhang, H., Ren, L., Zeng, J., Wen, Y., Shu, H., & Gong, G. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090167 · Cited by 1 · see citing works
Functional connectivity profiles of amygdala subregions in posttraumatic stress disorder
Haris, E. M., Bryant, R. A., Felmingham, K. L., Williams, L. M., & Korgaonkar, M. S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03508-y · Cited by 1 · see citing works
Guo, X., Zhang, L., Zhang, Q., Kendrick, K. M., & Yao, S. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106679 · Cited by 1 · see citing works
Yuanxiao, M. A., & Xu, C. H. E. N. (2022) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2023.00010 · Cited by 1 · see citing works
Meier, I. M., Montoya, E. R., Spencer, H., Orellana, S. C., van Buuren, M., van Honk, J., & Bos, P. A. (2022) · Developmental Psychobiology · doi:10.1002/dev.22349 · Cited by 1 · see citing works
Tracking effects of oxytocin crossing the blood brain barrier in vivo and in vitro
Chakraborty, T. (2024) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/6tnt-6n23
The Neurobiology of Resilience
Feder, A., Horn, S. R. G.-V., Haglund, M., Southwick, S. M., & Charney, D. S. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0038
Tell me who you sleep with, and I will tell you how good your sleep is
Suchecki, D. (2025) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2025.102098
Haris, E. M., Steward, T., Felmingham, K. L., Harrison, B. J., Davey, C. G., Moffat, B. A., Glarin, R. K., Bryant, R. A., & Korgaonkar, M. S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03428-9
Samonek, K., Basol, E. Z., Estrada, S., Davydovska, T., Funaro, M. C., & Harpaz‐Rotem, I. (2026) · Chronic Stress · doi:10.1177/24705470261427216
Zheng, S., Prounis, G. S., & Ophir, A. G. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1772423
Circuit logic of oxytocin and vasopressin complementary actions
Jeanneteau, F. D., Chakraborty, P., Petitjean, H., & Charlet, A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1875731
魏百慧, Li, X., & Che, X. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107050
- Authors
- Koch, S. B., van Zuiden, M., Nawijn, L., Frijling, J. L., Veltman, D. J., & Olff, M.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Koch, Saskia BJ
- Venue
- Neuropsychopharmacology
- Published
- 2015-09-25
- Volume
- 41
- Issue
- 6
- Pages
- 1495-1504
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC4832009
- OpenAlex
- W2315243510
- Cited by
- 98
- References
- 66
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 11 · 2020: 6 · 2019: 9 · 2018: 12 · 2017: 14 · 2016: 10 · 2015: 1
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- oxytocin, post-traumatic stress disorder, amygdala reactivity, emotional facial expressions, sex differences, police officers, augmentation therapy, anxiety, trauma exposure, neuroimaging
- MeSH terms
- Administration, Intranasal, Adult, Amygdala, Brain, Double-Blind Method, Emotions, Facial Expression, Female, Humans, Magnetic Resonance Imaging, Male, Oxytocin, Stress Disorders, Post-Traumatic, Anti-Anxiety Agents, Cross-Over Studies, Functional Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review